Please login to the form below

Not currently logged in
Email:
Password:

Asian patient groups give pharma above average marks for reputation

PatientView survey finds 49% believe sector has a good corporate reputation

PatientViewAsian patient groups have an above average impression of pharmaceutical companies, according to a new report.

New data from PatientView’s established corporate reputation survey show 49% of patient groups in Asia believe the sector has an ‘excellent’ or ‘good’ corporate reputation.

The figures, drawn from 98 patient groups from Australasia, Central Asia, East Asia, South Asia and South-East Asia, present a rosier picture than their counterparts from around the world, 37% of which held the same view.

PatientView’s 2016 Corporate Reputation of Pharma Companies survey covers the efforts of 16 global pharma companies including Pfizer - which was ranked the most familiar to the Asian patient groups.

Respondents also ranked AbbVie as overall first for corporate reputation among the groups familiar with the firm. The US company ranked first for patient-centricity, transparency and patient-group relations as well.

Meanwhile, GSK was placed first for the provision of ‘high-quality’ patient information and Novo Nordisk took first position for patient safety, high quality products and integrity.

Article by
Gemma Jones

16th June 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics